www.fdanews.com/articles/123954-watson-files-anda-for-loseasonique
Watson Files ANDA for LoSeasonique
January 25, 2010
Watson Pharmaceuticals has filed an ANDA to market a generic version
of Teva Pharmaceutical Industries’ LoSeasonique, an oral contraceptive. The
company is seeking approval for its contraceptive containing 0.1 mg ethinyl estradiol and 0.02 mg levonorgestrel before LoSeasonique’s U.S. patent
expires, Watson said. The patent is owned by Duramed Pharmaceuticals, a subsidiary of Teva.
Generic Line
Generic Line